Expression of the mdr1 and mdr3 gene products in acute and chronic leukemias

Leukemia Research

Volumn 21, Issue 4, 1997, Pages 313-319

  Aral, Yukari ^a   Masuda, Michihiko ^a   Sugawara, Isamu ^b   Arai, Tsutomu ^b   Motoji, Toshiko ^a   Tsuruo, Takashi ^d   Oshimi, Kazuo ^c   Mizoguchi, Hideaki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Mdr1; Mdr3; P glycoprotein

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAUNORUBICIN; DOXORUBICIN; ENOCITABINE; GLYCOPROTEIN P; MERCAPTOPURINE; METHOTREXATE; MONOCLONAL ANTIBODY; PREDNISOLONE; RHODAMINE 123; VINCRISTINE;

ACUTE LEUKEMIA; ARTICLE; CHRONIC LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DRUG EXPOSURE; DRUG TRANSPORT; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYELOPROLIFERATIVE DISORDER; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LEUKEMIA; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; AMINO ACID SEQUENCE; ATP-BINDING CASSETTE TRANSPORTERS; CHRONIC DISEASE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; P-GLYCOPROTEIN; P-GLYCOPROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030898813     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00130-0     Document Type: Article

References (33)

1. Chin, J. E., Soffir, R., Noonan, K. E., Choi, K. & Robinson, I. B. Structure and expression of the human MDR (P-glycoprotein) gene family. Molecular Cell Biology, 1989, 9, 3808.
2. Lincke, C. R., Smit, J. J. M., van der Velde-Koerts, T. & Borst, P. Structure of the human MDR3 gene and physical mapping of the human MDR locus. Journal of Biological Chemistry, 1991, 266, 5303.
3. Hamada, H. & Tsuruo, T. Functional role for the 170 to 180 Kda glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proceedings of the National Academy of Sciences, U.S.A., 1986, 83, 7785.
4. Gros, P., Raymond, M., Bel, J. & Housman, D. Cloning and characterization of a second member of the mouse mdr gene family. Molecular Cell Biology, 1988, 8, 2772.
5. Smit, J. J. M., Schinkel, A. H., Oudeelferink, R. P. J., Groen, A. K., Wagenaar, E., van Deeemter, I., Mol, C. A. A. M., Otenhoff, R., van der Lugt, N. M. T., van der Lugt, T., van Roon, M. A., van der Valk, M. A., Offerhaus, G. J. A., Berns, A. J. M. & Borst, P. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell, 1993, 75, 451.
6. Nooter, K., Sonneveld, P., Janssen, A., Oostrum, R., Boersma, T., Herweijer, H., Valerio, D., Hagemeuer, A. & Baas, F. Expression of the mdr3 gene in prolymphocytic leukemia: Association with cyclosporin-A-induced increase in drug accumulation. International Journal of Cancer, 1990, 45, 626.
7. Herweijer, H., Sonneveld, P., Baas, F. & Nooter, K. Expression of mdrl and mdr3 multi-drug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporin. Journal of the National Cancer Institute, 1990, 82, 1133.
8. Sonneveld, P., Nooter, K., Burghouts, J. T. M., Herweijer, H., Adriaansen, H. J. & Dongen, J. J. M. High expression of mdr3 multidrug-resistance gene in advanced-stage chronic lymphocytic leukemia. Blood, 1992, 79, 1496.
9. Sugawara, I., Hirata, A., Ueda, K. & Itoyama, S. Preparation and characterization of murine monoclonal antibody (MDR3M) reactive with mdr3 gene product. Japanese Journal of Cancer Research, 1992, 83, 795.
10. Schinkel, A. H., Roelofs, M. E. M. & Borst, P. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Research, 1991, 51, 2628.
11. Tsuruo, T., Sugimoto, Y. & Hamada, H. Detection of multidrug resistance markers, P-glycoprotein and mdr1 mRNA, in human leukemia cells. Japanese Journal of Cancer Research, 1987, 78, 1415.
12. Chaudhary, P. M. & Roninsonn, I. B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell, 1991, 66, 85.
13. Kurzberg, J., Waldman, T. A., Davey, M. P., Bigner, S. H., Moore, J. O., Hershfield, M. S. & Haynes B. F. CD7+, CD4-, CD8-acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells. Blood, 1989, 73, 381.
14. Masuda, M., Arai, Y., Osawa, M., Kaneko, T., Aoyama, M., Motoji, T., Oshimi, K. & Mizoguchi, H. Heterogeneity of CD7+3-1-4-8-leukemia with cytoplasmic antigens for subclassification. Leukemia, 1993, 7, 1759.
15. Oshimi, K., Yamada, O., Kaneko, T., Nishinarita, S., Iizuka, Y., Urabe, A., Inamori, T., Asano, S., Takahashi, S., Hattori, M., Naohara, T., Ohira, Y., Masuda, Y., Okubo, Y., Furusawa, S., Sakamoto, S., Omine, M., Mori, M., Tatsumi, E. & Mizoguchi, H. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia, 1993, 7, 782.
16. Loughran, T. P. Clonal disease of large granular lymphocytes. Blood, 1993, 82, 13.
17. Ohno, R., Okumura, M., Yokomaku, S., Ito, Y., Yano, K., Sugiura, I., Kataoka, T., Tanimoto, M., Kumazawa, K., Murase, T., Kojima, T., Tanimoto, M., Morishita, Y., Nagura, E., Ogura, M., Morishita, Y., Kodera, Y., Kawashima, K. & Saito, H. Intensified induction therapy with behenoyl cytosine arabinoside, daunorubicin, 6-mercaptopurine and prednisolone (BHAC-DMP (II)) therapy for acute myelogenous leukemia in adults and prognotic factors related to remission duration. Acta Haematologica Japan, 1990, 53, 705.
18. Gee, T. S., Haghbin, M., Dowling, M. D., Cunningham, I., Middleman, M. P. & Clarkson, B. D. Acute lymphoblastic leukemia in adults and children - difference in response with similar therapeutic regimens. Cancer, 1975, 37, 1256.
19. Clarkson, B., Ellis, S., Little, C, Gee, T., Arlin, Z., Mertelsmann, R., Andreeff, M., Kempin, S., Koziner, B., Chaganti, R., Jhanwar, S., Mckenzie, S., Cirrincione, C. & Gaynor, J. Acute lymphoblastic leukemia in adults. Seminars in Oncology, 1985, 12, 160.
20. Portlock, C. S. 'Good risk' non-Hodgkin's lymphomas. Approach to management. Seminars in Oncology, 1983, 20, 25.
21. Herweijer, H., Nooter, K., Beinshuizen, A., Sonneveld, P., Oostrum, R. G., Hesseling-Janssen, A. L. W. & van Dongen, J. J. M. Expression of mdr1 and mdr3 multidrug-resistance genes in hairy cell leukemia. European Journal of Cancer, 1991, 27, 297.
22. Yamamoto, T., Iwasaki, T., Watanabe, N., Oshimi, K., Naito, M., Tsuruo, T. & Kobayashi, Y. Expression of multidrug resistance P-glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte-proliferative disorder. Blood, 1993, 81, 1342.
23. te Boekhost, P. A. W., de Leeuw, K., Schoester, M., Wittebol, S., Nooter, K., Hagemeijer, A., Lowenberg, B. & Sonneveld, P. Predominance of functional multidrug resistance (MDR1) phenotype in CD34+ acute myeloid leukemia cells. Blood, 1993, 82, 3157.
24. Goasguen, J. E., Dossot, J.-M., Fardel, O., Le Mee, F., Le Gall, E., Leblay, R., Leprise, P. Y., Chaperon, J. & Fauchet, R. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia prognostic implications. Blood, 1993, 81, 2394.
25. Tsuruo, T., Iida, H. & Tsukagoshi, S. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Research, 1982, 42, 4730.
26. Kessel, D. & Wilberding, C. Mode of action of calcium antagonists which alter anthracycline resistance. Biochemistry and Pharmacology, 1984, 33, 1157.
27. Yalowich, J. C. & Ross, W. E. Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro. Cancer Research, 1985, 65, 1651.
28. Nooter, K., Oostrum, R. & Jonker, R. R. Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistance P388 leukemia cells measured by real-time flow cytometry. Cancer Chemotherapy and Pharmacology, 1989, 23, 296.
29. Naito, M. & Tsuruo, T. Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium iron involvement. Cancer Research, 1989, 49, 1452.
30. Herweijer, H., Van den Engh, G. J. & Nooter, K. A rapid and sensitive flow cytometric method for the detection of multidrug-resistant cells. Cytometry, 1989, 10, 463.
31. Silbermann, M. H., Boersma, A. W. M. & Janssen, A. L. W. Effects of cyclosporin A and verapamil on the intracellular daunorubicin accumulation of Chinese hamster ovary cells with increasing levels of drug-resistance. International Journal of Cancer, 1989, 44, 722.
32. Michieli, M., Damiani, D., Geromin, A., Michelutti, A., Fanin, R., Raspadori, D., Russo, D., Visani, G., Dinota, A., Pileri, S., Tsuruo, T., Grandi, M., Baccarani, M. & Tura, S. Overexpression of multidrug resistance-associated p170-glycoprotein in acute non-lymphocytic leukemia. European Journal of Haematology, 1991, 48, 87.
33. Rouby, S. E. I., Thomas, A., Costin, D., Rosenberg, C. R., Potmesil, M., Silver, R. & Newcomb, E. W. p53 Gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood, 1993, 82, 3452.